Strategies to improve quality of life in bladder cancer patients

被引:3
作者
Roaldsen, Marius [1 ,2 ]
Aarsaether, Erling [1 ,2 ]
Knutsen, Tore [1 ]
Patel, Hiten R. H. [1 ,2 ]
机构
[1] Univ Hosp North Norway, Dept Urol & Endocrine Surg, N-9038 Tromso, Norway
[2] Univ Tromso, Inst Clin Med, N-9037 Tromso, Norway
关键词
bladder cancer; ERAS; evidence-based medicine; guidelines; oncology; quality of life; shared decision-making; INVASIVE UROTHELIAL CARCINOMA; TRANSURETHRAL RESECTION; RADICAL CYSTECTOMY; URINARY-DIVERSION; DECISION AIDS; CHEMOTHERAPY; THERAPY; PRESERVATION; GUIDELINES; RADIATION;
D O I
10.1586/14737167.2014.917967
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Bladder cancer is a heterogeneous disease that includes both tumors with low risk of dissemination as well as highly malignant tumors with a considerable potential to metastasize. The patient's quality of life is closely related to the management of the disease. The challenge for the urologist is to acknowledge the malignant potential of the cancer and to adjust the approach to the patient accordingly. Patients with low-risk bladder cancer should avoid an exaggerated follow-up, but on the other hand high-risk patients must be sufficiently surveyed to secure that definitive surgical treatment is performed before it's too late. When the decision to perform a cystectomy has been made, it is crucial that the patient understands the consequences of the surgery as well as the possible options for urinary reconstruction. This review focuses on aspects of bladder cancer management that we believe are vital for the quality of life of these patients.
引用
收藏
页码:537 / 544
页数:8
相关论文
共 63 条
  • [1] [Anonymous], 2014, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001431.PUB4
  • [2] [Anonymous], J UROL
  • [3] Quality of life after radical cystectomy for bladder cancer in men with an ileal conduit or continent urinary diversion: A comparative study
    Asgari, M. A.
    Safarinejad, M. R.
    Shakhssalim, N.
    Soleimani, M.
    Shahabi, A.
    Amini, E.
    [J]. UROLOGY ANNALS, 2013, 5 (03) : 190 - 196
  • [4] The First 100 Consecutive, Robot-assisted, Intracorporeal Ileal Conduits: Evolution of Technique and 90-day Outcomes
    Azzouni, Faris S.
    Din, Rakeeba
    Rehman, Shabnam
    Khan, Aabroo
    Shi, Yi
    Stegemann, Andrew
    Sharif, Mohammad
    Wilding, Gregory E.
    Guru, Khurshid A.
    [J]. EUROPEAN UROLOGY, 2013, 63 (04) : 637 - 643
  • [5] EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
    Babjuk, Marko
    Burger, Maximilian
    Zigeuner, Richard
    Shariat, Shahrokh F.
    van Rhijn, Bas W. G.
    Comperat, Eva
    Sylvester, Richard J.
    Kaasinen, Eero
    Boehle, Andreas
    Palou Redorta, Joan
    Roupret, Morgan
    [J]. EUROPEAN UROLOGY, 2013, 64 (04) : 639 - 653
  • [6] Primary Bladder Preservation Treatment for Urothelial Bladder Cancer
    Biagioli, Matthew C.
    Fernandez, Daniel C.
    Spiess, Philippe E.
    Wilder, Richard B.
    [J]. CANCER CONTROL, 2013, 20 (03) : 188 - 199
  • [7] Quality of life aspects of bladder cancer: A review of the literature
    Botteman, MF
    Pashos, CL
    Hauser, RS
    Laskin, BL
    Redaelli, A
    [J]. QUALITY OF LIFE RESEARCH, 2003, 12 (06) : 675 - 688
  • [8] Caffo O, 1996, CANCER, V78, P1089, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1089::AID-CNCR20>3.3.CO
  • [9] 2-B
  • [10] Trimodality treatment in the conservative management of infiltrating bladder cancer: A critical review of the literature
    Caffo, Orazio
    Veccia, Antonello
    Fellin, Gianni
    Russo, Lucianna
    Mussari, Salvatore
    Galligioni, Enzo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 86 (02) : 176 - 190